(Reuters) - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/hT6TI5exfVA/story01.htm
Read More
No comments:
Post a Comment